Zhao Yan New Medicine (06127.HK): The directors and senior executives of the company plan to collectively reduce their holdings of the company's A shares by no more than 848,300 shares.

Financial News app message: Zhaoyan Pharmaceuticals (06127.HK) announced that Sun Yunxia, Gao Dapeng, and Gu Jingliang plan to reduce their holdings by no more than 674,700 shares, 72,100 shares, and 67,400 shares respectively through block trading or centralized bidding on the Shanghai Stock Exchange from September 30, 2025 to November 28, 2025, starting 15 trading days after the announcement of the reduction plan. Li Ye and Yu Aishui plan to reduce their holdings by no more than 25,600 shares and 8,500 shares respectively through centralized bidding on the Shanghai Stock Exchange from September 30, 2025 to November 28, 2025, starting 15 trading days after the announcement of the reduction plan. The total reduction amount does not exceed 848,300 shares, which is 0.1132% of the company's current total share capital. During the implementation period of the reduction plan, if the company undergoes events such as bonus shares, capital increase, issuance of new shares, or rights issue, the reduction quantity will be adjusted accordingly. The reduction price will be determined based on market prices.